Results 101 to 110 of about 5,865 (155)

[Prognostic value of high-risk cytogenetic abnormalities inmultiple myeloma]. [PDF]

Zhonghua Xue Ye Xue Za Zhi
Shen XX, Yu JP, Guo R, Xu Y, Jin YY, Shi QL, Chen LJ.   +6 more
europepmc   +1 more source

[Detection of cytogenetic abnormalities in multiple myeloma by using optical genome mapping]. [PDF]

Zhonghua Xue Ye Xue Za Zhi
Wang YF, Zhang ZH, Wang H, Xi LY, Dong F, Jing HM.   +5 more
europepmc   +1 more source

[Cytoplasmic light-chain immunofluorescence combined with FISH in bone marrow smears to detect cytogenetic abnormalities in multiple myeloma]. [PDF]

Zhonghua Xue Ye Xue Za Zhi
Shi Y, Yang H, Guo R, Guo Z, Li JY, Wu YJ, Qiu HR.   +6 more
europepmc   +1 more source

PEST-SWOT analysis on application of unmanned aerial vehicle in health emergency response of chemical poisoning [PDF]

, 2023
TANG Shihao, WANG Zhi
core   +1 more source

[Chinese guidelines for diagnosis and treatment of myelodysplastic neoplasms (2026)]. [PDF]

Zhonghua Xue Ye Xue Za Zhi
Chinese Society of Hematology, Chinese Medical Association.   +1 more
europepmc   +1 more source

[How I diagnose and treat chronic myelomonocytic leukemia]. [PDF]

Zhonghua Xue Ye Xue Za Zhi
Xiao ZJ.
europepmc   +1 more source

急性髓细胞白血病（M₂b）与染色体8;21易位——附45例报告

Zhongguo shiyan zhenduanxue, 1997
为了更加准确诊断急性髓细胞白血病（ＡＭＬ）的Ｍ２ｂ型，本文联合常规的细胞形态学、细胞化学、细胞遗传学和分子生物学方法对４５例伴ｔ（８；２１）易位的ＡＭＬ患者进行诊断。结果显示：①染色体ｔ（８；２１）易位与Ｍ２ｂ两者关系密切。本组４５例ｔ（８；２１）ＡＭＬ中Ｍ２ｂ占９７．７％。ｔ（８；２１）常伴性染色体丢失，以Ｙ染色体丢失尤为易见。②异常中幼粒特征性改变主要是高度核浆发育不平衡（不成熟的核与成熟的胞浆），占６％～６６％，中位数３３％。３２例可见Ａｕｅｒ小体，６例骨髓嗜酸细胞明显增多（＞５％）。③用逆转录酶／
doaj  

[Clinical characteristics of DUX4-IGH fusion B-cell acute lymphoblastic leukemia in children]. [PDF]

Zhongguo Dang Dai Er Ke Za Zhi
Luo YX, Jiang H, Wang JY, Hao WG, Zhang WN.   +4 more
europepmc   +1 more source

[Research progress on lactylation modification in pathogenesis of osteoarthritis]. [PDF]

Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi
Wu Y, Sun K, Ding Y, Li M, Liu Y, Wu L, Peng L, Shen B.   +7 more
europepmc   +1 more source

[Efficacy and safety of venetoclax-cytarabine-homoharringtonine-based cytoreductive therapy before allogeneic hematopoietic stem cell transplantation in refractory/relapsed acute myeloid leukemia with RUNX1::RUNX1T1: a retrospective study]. [PDF]

Zhonghua Xue Ye Xue Za Zhi
Zhang ZL, Jin CW, Li S, Wang LX, Huang JY, Jiang CH, Lu HY, Hu XX.   +7 more
europepmc   +1 more source